Copyright
©The Author(s) 2015.
World J Gastrointest Pathophysiol. Nov 15, 2015; 6(4): 235-242
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.235
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.235
Table 2 Univariate and multivariate cox regression comparing individual drug groups with those not taking the drug
| Drug name | Number taking the drug out of 164 patients | Univariate analysis | Multivariate analysis | ||
| HR (95%CI) | P-value | HR (95%CI) | P-value | ||
| ACEI/ARB | 41 | 1.094 (0.741-1.614) | 0.653 | 1.129 (0.617-2.065) | 0.693 |
| CCB | 26 | 0.635 (0.393-1.025) | 0.063 | 0.475 (0.250-0.902) | 0.023 |
| Aspirin | 55 | 1.036 (0.726-1.479) | 0.846 | 1.041 (0.651-1.667) | 0.865 |
| Statins | 39 | 1.200 (0.806-1.787) | 0.369 | 1.055 (0.614-1.814) | 0.845 |
- Citation: Tingle SJ, Moir JA, White SA. Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. World J Gastrointest Pathophysiol 2015; 6(4): 235-242
- URL: https://www.wjgnet.com/2150-5330/full/v6/i4/235.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v6.i4.235